The Deciparticle ™ platform is a proprietary nanotechnology engineered to encapsulate hydrophobic molecules as uniform, sub-20 nm nanoparticles for intravenous administration. The platform improves ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano, a clinical-stage nanomedicine company, today announced new data ...
New data to be presented at the 2025 AES Annual Meeting indicate sustained reductions in seizure frequency as early as two weeks after treatment ...
AI WAS a highlight of the 2025 European Society for Medical Oncology (ESMO) Congress, held in Berlin, Germany, with sessions ...
Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received ...
CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
IDEAYA Biosciences, Inc. ( IDYA) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:00 AM EST ...
Detailed price information for Upstream Bio Inc (UPB-Q) from The Globe and Mail including charting and trades.
GUELPH, ON – November 24, 2025 – PRESSADVANTAGE – Natural Choice Medical Clinic is outlining a practical, evidence-based approach to menopause treatment for residents of Elora and surrounding ...
Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results